Journal article icon

Journal article

Severe Plasmodium falciparum malaria: targets and mechanisms associated with protection in Kenyan children.

Abstract:
Severe malaria (SM) is a life-threatening complication of infection with Plasmodium falciparum. Epidemiological observations have long indicated that immunity against SM is acquired relatively rapidly, but prospective studies to investigate its immunological basis are logistically challenging and have rarely been undertaken. We investigated the merozoite targets and antibody-mediated mechanisms associated with protection against SM in Kenyan children aged 0 to 2 years. We designed a unique prospective matched case-control study of well-characterized SM clinical phenotypes nested within a longitudinal birth cohort of children (n = 5,949) monitored over the first 2 years of life. We quantified immunological parameters in sera collected before the SM event in cases and their individually matched controls to evaluate the prospective odds of developing SM in the first 2 years of life. Anti-AMA1 antibodies were associated with a significant reduction in the odds of developing SM (odds ratio [OR] = 0.37; 95% confidence interval [CI] = 0.15 to 0.90; P = 0.029) after adjustment for responses to all other merozoite antigens tested, while those against MSP-2, MSP-3, Plasmodium falciparum Rh2 [PfRh2], MSP-119, and the infected red blood cell surface antigens were not. The combined ability of total IgG to inhibit parasite growth and mediate the release of reactive oxygen species from neutrophils was associated with a marked reduction in the odds of developing SM (OR = 0.07; 95% CI = 0.006 to 0.82; P = 0.03). Assays of these two functional mechanisms were poorly correlated (Spearman rank correlation coefficient [rs] = 0.12; P = 0.07). Our data provide epidemiological evidence that multiple antibody-dependent mechanisms contribute to protective immunity via distinct targets whose identification could accelerate the development of vaccines to protect against SM.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1128/IAI.01120-15

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Jenner Institute
Role:
Author


More from this funder
Funding agency for:
Murungi, L
Osier, F
Grant:
084538/Z/07/B
MR/L00450X/1
More from this funder
Funding agency for:
Osier, F
Draper, S
Grant:
MR/L00450X/1
G1000527
More from this funder
Funding agency for:
Llewellyn, D


Publisher:
American Society for Microbiology
Journal:
Infection and Immunity More from this journal
Pages:
IAI.01120-15-IAI.01120-15
Publication date:
2016-01-19
Acceptance date:
2016-01-14
DOI:
EISSN:
1098-5522
ISSN:
0019-9567


Language:
English
Pubs id:
pubs:598034
UUID:
uuid:638a8097-c509-492d-ad8d-37cdb12929db
Local pid:
pubs:598034
Source identifiers:
598034
Deposit date:
2016-03-29

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP